COVID patients on SSRI antidepressants are less likely to die, study finds

A large analysis of health records from 87 health care centers across the United States found that people taking a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs), particularly fluoxetine, were significantly less likely to die of COVID-19 than a matched control group.

source https://www.sciencedaily.com/releases/2021/11/211115123538.htm